Sydney TMS Treatment & Neurostimulation Centre
The Sydney TMS Treatment & Neurostimulation Centre is a research, clinical assessment and treatment centre which is led by the internationally respected psychiatrist and researcher Professor Colleen Loo. Professor Loo has expertise derived from 20 years of experience in the treatment of mental illnesses using evidence-based brain stimulation interventions.
The Transcranial Magnetic Stimulation (TMS) Clinic provides treatment on a fee for service basis. TMS is a non-invasive brain stimulation technique to treat depression and other psychiatric disorders. A large body of research conducted worldwide and at our centre indicates that TMS has antidepressant effects when applied over the frontal areas of the brain. It is now an approved treatment for depression in Australia by the Royal Australian and New Zealand College of Psychiatrists.
Download our TMSFactSheet for more information about the treatment.
In addition to standard TMS, the TMS Clinic now provides a new form of TMS treatment called Deep TMS. Deep TMS is only currently available in Australia as a clinical treatment at the Black Dog Institute. Compared to standard TMS, Deep TMS provides stimulation to deeper brain regions affected in depression. An international trial has demonstrated the safety and effectiveness of Deep TMS for patients with treatment-resistant depression. Deep TMS is approved by the U.S. Food & Drug Administration (FDA) and
AustralianTherapeutic Goods Administration as a therapy for treatment-resistant depression.
Download our dTMS fact sheet for more information about the treatment.
As there are many brain regions that can be affected during
depression, our clinic psychiatrists will assess on a case-by-case basis whether Deep TMS or standard TMS is most suitable for the individual.
The Neurostimulation Clinic offers a referral service providing a specialist assessment on the potential benefit to patients of brain stimulation treatments including electroconvulsive therapy, transcranial magnetic stimulation and direct current stimulation as well as other novel treatments for depression such as ketamine.
The assessment cost is partially rebatable through Medicare.
A referral letter from a psychiatrist or GP is required. Referrals can be emailed to firstname.lastname@example.org or fax (02) 9382 8208 (Attn: Prof Colleen Loo).
Designed for clinicians and researchers, the courses are facilitated by leading experts in neurostimulation and mood disorders, Prof. Colleen Loo and the Sydney Neurostimulation Centre team.
Two-day certificate course in TMS
Introductory 2-day course on theory and techniques, including hands-on practice in administering TMS.
One-day course in tDCS
For psychiatrists, mental health nurses and researchers, this introductory course focuses on tDCS principles, effects in psychiatric disorders, and practical techniques through hands-on workshops.
Certificate courses in electroconvulsive therapy for psychiatrists and health professionals
Professor Loo also facilitates a 2-day Advanced ECT course designed for the experienced ECT practitioner. The course covers strategies for managing the complex ECT patient and updates on latest advances in ECT.
Further information can be found here: 2-Day ECT Refresher - Advanced Course
We are always seeking participants for our treatment trials. This is an opportunity for you to access treatments that are not yet widely available.
Ketamine to treat depression
Black Dog Institute researchers have demonstrated the enormous potential of ketamine as a new treatment for major depression.
Whilst ketamine is approved for use in anaesthesia, it has not received approval for use in depression. This is because there are still significant gaps in our knowledge about dosage levels, treatment protocols and the effectiveness and safety of long term use. UNSW Professor Colleen Loo and her team have done some pioneering work in answering these important questions.
We are pleased to announce that the NH&MRC have provided funding to establish a national clinical trial into ketamine. This study will commence in mid-2016 with trial locations based in Sydney, Melbourne, Adelaide, Perth and Dunedin (NZ).
You can find out more about participation in this trial at the ketamine to treat depression page
Professor Colleen Loo, School of Psychiatry, UNSW Sydney; Professorial Fellow, The Black Dog Institute, is a psychiatrist and clinical academic based at St George Hospital and the Black Dog Institute. She is also Medical Director of the electroconvulsive therapy (ECT) service at Wesley Hospital Kogarah.
Angelo Alonzo completed his studies in Psychology at the University of New South Wales with a BSc (Class 1 Hons) and PhD in cognitive psychology. Upon finishing, he worked in China teaching Introductory Psychology at the Missouri State University branch campus in Dalian and Advanced English at Huaqiao University in Quanzhou. He has worked at the Black Dog Institute since 2008, co-ordinating the clinical research trials of the Sydney Neurostimulation Centre involving novel brain stimulation techniques such as transcranial Direct Current Stimulation and Transcranial Magnetic Stimulation for the treatment of depression.
Dr Donel Martin is a clinical neuropsychologist and post-doctoral researcher based at the Black Dog Institute. His research interests include investigating novel treatments for psychiatric disorders, including novel brain stimulation techniques (e.g. transcranial direct current stimulation [tDCS]), and using brain stimulation to enhance cognitive functioning. He is currently involved in research investigating the use of novel forms of brain stimulation to enhance cognitive functioning in bipolar disorder, schizophrenia, and mild cognitive impairment.
Stevan received his Bachelor of Science, specialising in Psychology and Physics, in 2008 and his Master of Commerce in 2010 from UNSW, and has over 5 years research experience in the fields of injury prevention and neuroscience. He is currently conducting research on the use of brain monitoring systems to understand the effects of transcranial direct current stimulation.
Rohan Taylor is a Psychiatrist and PhD candidate at the University of NSW – his current research examines the impact of variations in anaesthetic technique on ECT outcomes. Rohan works clinically in the Canterbury Older Persons Mental Health Team, and has been assessing and treating patients with TMS as part of the Sydney Neurostimulation Centre since 2015. He completed a Bachelor of Liberal Studies (International) in 2006, and MBBS in 2010 at the University of Sydney - Rohan completed his RANZCP Fellowship in February 2018, and is the recipient of a HETI Research Fellowship in 2018.
To make an enquiry or provide some feedback (positive or negative), please:
- send an email to email@example.com; or
- call Michael Kabourakis on (02) 9382 8318.